J8499 HCPCS Level II code: Prescription drug, oral, non chemotherapeutic, nos
J8499 is the HCPCS code for “Prescription drug, oral, non chemotherapeutic, nos” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8499Prescription drug, oral, non chemotherapeutic, nos
Short description: Oral prescrip drug non chemo
HCPCS · United States
Medicare details
The indicators CMS publishes with J8499 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1995
Where J8499 sits
- 1J codesDrugs administered other than orally
- 2Active code J8499Prescription drug, oral, non chemotherapeutic, nos
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8499 mean?
J8499 is the HCPCS code for “Prescription drug, oral, non chemotherapeutic, nos” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8499?
CMS lists J8499’s Medicare coverage as “Non-covered by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8499
All J codesJ7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligramsJ7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mgJ7699Noc drugs, inhalation solution administered through dmeJ7799Noc drugs, other than inhalation drugs, administered through dmeJ7999Compounded drug, not otherwise classifiedJ8498Antiemetic drug, rectal/suppository, not otherwise specifiedJ8501Aprepitant, oral, 5 mgJ8502Injection, aprepitant (aponvie), 1 mgJ8510Busulfan; oral, 2 mgJ8515Cabergoline, oral, 0.25 mgJ8520Capecitabine, oral, 150 mgJ8521Capecitabine, oral, 500 mg